Stable aqueous formulations of adalimumab
US9382317B2 · kind B2 · utility
45Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2015 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Mar 18, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.